Uniphar IPO to finance group's next acquisition phase

Pharmacy and healthcare services group Uniphar will use the proceeds of its planned stock market flotation to pay for near-term acquisition targets and to reduce its debt levels.

The pharmaceutical wholesale, distribution and retail group said it intends to float on both the Euronext Dublin - or Irish Stock Exchange - and London's AIM market as early as next month.